Literature DB >> 403001

Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.

T Kataoka, F Oh-hashi, S Tsukagoshi, Y Sakurai.   

Abstract

Immunization with L1210 mouse leukemia cells treated with glutaraldehyde and concanavalin A resulted in the induction of leukemia-specific immune resistance in BALB/c X DBA/2Cr F1 mice. This was measured by survival of the mice after challenge either with the intact cells or with modified leukemia cells of less malignancy. Factors involved in the induction of immunoprophylaxis were analyzed. To produce an immune response against L1210 cells, preincubation with both glutaraldehyde and concanavalin A was required. Repeated sensitization with this combination produced higher incidences of survivors upon subsequent challenge with L1210 cells than did a single sensitization by equivalent or larger doses. However, the sensitization was rendered less effective by repetition of the immunization process five times.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403001

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Immuno-protective effect of tumor cell vaccine on Kunming mice bearing Ehrlich ascites tumor.

Authors:  Zheng Ma; Shao-Juan Zhou; Kai-Chun Wu; Bo-Rong Pan; Tai-Dong Qiao; Bao-Jun Chen; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  I-Ad antigen expression of pyran copolymer-induced peritoneal cells in tumor vaccine-primed mice and its association with the host antitumor response.

Authors:  F Oh-hashi; T Kataoka; T Taniyama
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Feasibility of UV-inactivated vaccinia virus in the modification of tumor cells for augmentation of their immunogenicity.

Authors:  N Wakamiya; Y L Wang; H Imai; H X Gu; S Ueda; S Kato
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Effect of levamisole on cytotoxic T-cell-mediated immune resistance to L1210 murine leukemia in hyperimmune mice.

Authors:  K Gomi; M Morimoto; T Kataoka
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Non-cytotoxic activity of pyran copolymer-induced macrophages associated with potentiation of tumour vaccine in recipient mice.

Authors:  T Kataoka; F Oh-hashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.

Authors:  S Ben-Efraim; R Ophir; E H Relyveld
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

7.  The induction of enhanced antitumor effect against a nonimmunogenic tumor by highly immunogenic variants obtained by mutagen treatment.

Authors:  R Sainouchi; N Terata; M Kodama
Journal:  Jpn J Cancer Res       Date:  1988-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.